New Treatments in Noninfectious Uveitis
Uveitis is a potentially blinding inflammatory disease that presents one of the most serious and complicated therapeutic challenges in the field of ophthalmology. During the last decade, the therapeutic armamentarium of the uveitis specialist has enormously expanded. Novel biologic agents and intraocular therapy are becoming a valuable alternative treatment to control ocular inflammatory diseases and inflammatory macular edema -- the most important cause of visual loss in patients with uveitis. This publication is designed to bring together the principles of therapy of patients with noninfectious uveitis and the most recent therapeutic options available. General ophthalmologists, uveitis specialists as well as residents will find it a useful update on the latest innovative treatment options for patients with noninfectious uveitis.
Download citation file:
Digital Version
Print Version
Table of Contents
-
1 - 6: The Philosophy of Treatment of Uveitis: Past, Present and FutureByJonathan Kruh;Jonathan KruhMassachusetts Eye Research and Surgery Institution, Ocular Immunology and Uveitis Foundation, Cambridge, Mass., USASearch for other works by this author on:C.Stephen FosterC.Stephen FosterMassachusetts Eye Research and Surgery Institution, Ocular Immunology and Uveitis Foundation, Cambridge, Mass., USASearch for other works by this author on:
-
7 - 28: The Gold Standard of Noninfectious Uveitis: CorticosteroidsByPhuc LeHoangPhuc LeHoangDepartment of Ophthalmology, University of Paris VI, Pitié-Salpêtrière Hospital, Paris, FranceSearch for other works by this author on:
-
29 - 46: Corticosteroid-Sparing Agents: Conventional Systemic ImmunosuppressantsByJonathan Kruh;Jonathan KruhMassachusetts Eye Research and Surgery Institution, Ocular Immunology and Uveitis Foundation, Cambridge, Mass., USASearch for other works by this author on:C. Stephen FosterC. Stephen FosterMassachusetts Eye Research and Surgery Institution, Ocular Immunology and Uveitis Foundation, Cambridge, Mass., USASearch for other works by this author on:
-
47 - 56: Corticosteroid-Sparing Agents: New Treatment OptionsByOren Tomkins-Netzer;Oren Tomkins-NetzeraRoyal Surrey County Hospital, Guildford, andbMoorfields Eye Hospital andSearch for other works by this author on:Simon R.J. Taylor;Simon R.J. TayloraRoyal Surrey County Hospital, Guildford, andbMoorfields Eye Hospital andcUCL Institute of Ophthalmology, London, UKSearch for other works by this author on:Sue LightmanSue LightmanaRoyal Surrey County Hospital, Guildford, andbMoorfields Eye Hospital andcUCL Institute of Ophthalmology, London, UKSearch for other works by this author on:
-
57 - 62: Mycophenolate Mofetil Use in the Treatment of Noninfectious UveitisByDino D. KlisovicDino D. KlisovicMidwest Retina, Dublin, Ohio, USASearch for other works by this author on:
-
63 - 78: Anti-Tumor Necrosis Factor-α Agents in Noninfectious UveitisByJulie Gueudry;Julie GueudryaDepartment of Ophthalmology, Charles Nicolle University Hospital, Rouen, andSearch for other works by this author on:Phuc LeHoang;Phuc LeHoangbDepartment of Ophthalmology, University of Paris VI, Pitié-Salpêtrière Hospital, Paris, FranceSearch for other works by this author on:Bahram BodaghiBahram BodaghibDepartment of Ophthalmology, University of Paris VI, Pitié-Salpêtrière Hospital, Paris, FranceSearch for other works by this author on:
-
79 - 89: New Biologic Drugs: Anti-Interleukin TherapyByChristoph Tappeiner;Christoph TappeineraDepartments of Ophthalmology andSearch for other works by this author on:Burkhard Möller;Burkhard MöllerbRheumatology, Allergology and Immunology, Inselspital, University of Bern, Bern, Switzerland;Search for other works by this author on:Maren Hennig;Maren HennigcDepartment of Ophthalmology, St. Franziskus Hospital, Münster, and University of Essen, Essen, GermanySearch for other works by this author on:Arnd HeiligenhausArnd HeiligenhauscDepartment of Ophthalmology, St. Franziskus Hospital, Münster, and University of Essen, Essen, GermanySearch for other works by this author on:
-
90 - 97: Interferon-α Therapy in Noninfectious UveitisByChristoph Deuter;Christoph DeuteraCentre for Ophthalmology, University of Tübingen, Tübingen, andSearch for other works by this author on:Nicole Stübiger;Nicole StübigerbDepartment of Ophthalmology, Campus Benjamin Franklin, Charité, Universitätsmedizin Berlin, Berlin, GermanySearch for other works by this author on:Manfred ZierhutManfred ZierhutaCentre for Ophthalmology, University of Tübingen, Tübingen, andSearch for other works by this author on:
-
98 - 109: Rituximab for Noninfectious UveitisByElisabetta Miserocchi;Elisabetta MiserocchiOcular Immunology and Uveitis Service, Department of Ophthalmology and Visual Sciences, San Raffaele Scientific Institute, University Vita-Salute, Milan, ItalySearch for other works by this author on:Giulio ModoratiGiulio ModoratiOcular Immunology and Uveitis Service, Department of Ophthalmology and Visual Sciences, San Raffaele Scientific Institute, University Vita-Salute, Milan, ItalySearch for other works by this author on:
-
110 - 121: Intravitreal Injection Therapy in the Treatment of Noninfectious UveitisByGiulio Modorati;Giulio ModoratiOcular Immunology and Uveitis Service, Department of Ophthalmology and Visual Sciences, San Raffaele Scientific Institute, University Vita-Salute, Milan, ItalySearch for other works by this author on:Elisabetta MiserocchiElisabetta MiserocchiOcular Immunology and Uveitis Service, Department of Ophthalmology and Visual Sciences, San Raffaele Scientific Institute, University Vita-Salute, Milan, ItalySearch for other works by this author on:
-
122 - 133: Corticosteroid Intravitreal ImplantsByMarc D. de SmetMarc D. de SmetRetina and Inflammation, MIOS, Lausanne, Switzerland, and Department of Ophthalmology, University of Amsterdam, Amsterdam, The NetherlandsSearch for other works by this author on:
-
134 - 161: New Treatment Options for Noninfectious UveitisByMillena Gomes Bittencourt;Millena Gomes BittencourtRetinal Imaging Research and Reading Center, Wilmer Eye Institute, Johns Hopkins University, Baltimore, Md., USASearch for other works by this author on:Yasir Jamal Sepah;Yasir Jamal SepahRetinal Imaging Research and Reading Center, Wilmer Eye Institute, Johns Hopkins University, Baltimore, Md., USASearch for other works by this author on:Diana V. Do;Diana V. DoRetinal Imaging Research and Reading Center, Wilmer Eye Institute, Johns Hopkins University, Baltimore, Md., USASearch for other works by this author on:Owhofasa Agbedia;Owhofasa AgbediaRetinal Imaging Research and Reading Center, Wilmer Eye Institute, Johns Hopkins University, Baltimore, Md., USASearch for other works by this author on:Abeer Akhtar;Abeer AkhtarRetinal Imaging Research and Reading Center, Wilmer Eye Institute, Johns Hopkins University, Baltimore, Md., USASearch for other works by this author on:Hongting Liu;Hongting LiuRetinal Imaging Research and Reading Center, Wilmer Eye Institute, Johns Hopkins University, Baltimore, Md., USASearch for other works by this author on:Anam Akhlaq;Anam AkhlaqRetinal Imaging Research and Reading Center, Wilmer Eye Institute, Johns Hopkins University, Baltimore, Md., USASearch for other works by this author on:Rachel Annam;Rachel AnnamRetinal Imaging Research and Reading Center, Wilmer Eye Institute, Johns Hopkins University, Baltimore, Md., USASearch for other works by this author on:Mohamed Ibrahim;Mohamed IbrahimRetinal Imaging Research and Reading Center, Wilmer Eye Institute, Johns Hopkins University, Baltimore, Md., USASearch for other works by this author on:Quan Dong NguyenQuan Dong NguyenRetinal Imaging Research and Reading Center, Wilmer Eye Institute, Johns Hopkins University, Baltimore, Md., USASearch for other works by this author on: